HOME >> BIOLOGY >> NEWS
Pioneering experiments testing effects of greenhouse gases on crops

CHAMPAIGN, Ill. Portions of 40 acres of University of Illinois farmland this summer are sprouting soybeans grown in the presence of carbon dioxide levels forecast for the year 2050. Next summer, elevated levels of ozone will join the mix in a first-of-its-kind experiment called SoyFACE.

"When you consider the importance of the Midwest in terms of global food security, it is important to do this research here," said Stephen P. Long, a photosynthesis expert and the Robert Emerson Professor of Plant Biology at the UI. "Up to now, experiments related to global warming on many crops have been done in locations on the periphery of major food production areas."

Researchers want to know how soybeans may be affected, and what scientists might do to assure the integrity of yields and quality as the climate changes. By 2050, carbon dioxide levels are expected to be about 1.5 times greater than the current 370 parts per million, while daytime ozone levels during the growing season could peak on average at 80 parts per billion (now 60 parts per billion).

SoyFACE (Free Air gas Concentration Enrichment) is the first test of crop growth in the presence of both increased carbon dioxide and ozone. Five UI departments, the USDA-ARS and Illinois State Water Survey, as well as researchers from four other nations and two other U.S. universities are participating this summer.

Four control and four experimental 70-foot-diameter rings currently surround 24 varieties of soybeans. The experimental rings have ABS plastic pipes that deliver at crop level a precisely regulated flow of carbon dioxide, based on wind speed and direction, pumped from a 50-ton solar-powered tank.

Next summer, soybeans will grow on an adjacent 40 acres dotted with 24 of the octagon-shaped rings. Four rings will pump carbon dioxide, four will provide just ozone and four will provide ozone and carbon dioxide. Natural conditions will exist in an equal number of control rings for each test
'"/>

Contact: Jim Barlow
b-james3@uiuc.edu
217-333-5802
University of Illinois at Urbana-Champaign
2-Jul-2001


Page: 1 2

Related biology news :

1. Pioneering AIDS researcher to speak at UH
2. Pioneering discoveries, pursuing new knowledge, fostering partnerships
3. Pioneering flu researcher wins major Imperial scientific award
4. Pioneering study compares 13 vertebrate genomes
5. UFS Mcknight Brain Institute researchers: Pioneering spinal cord procedure appears safe
6. Pioneering evolutionist Ledyard Stebbins dies at age 94
7. Pioneering Research Could Lead To Treatment
8. Sandia experiments may reduce possibility of future water wars
9. APS recognizes Intel high school finalists for experiments in physiology
10. BioScience seeks nominations of beauteous experiments
11. ALife experiments show how complex functions can evolve

Post Your Comments:
(Date:4/1/2015)... 2015   Medisafe ™, the leading global medication ... iOS and Android smartphones and tablets, ... the platform to allow patients to track and correlate ... time, patients will be able to visualize in real-time ... biometrics, such as glucose levels and blood pressure. ...
(Date:3/30/2015)... , Mar. 26, 2015 Research and Markets ... of the "Global Gesture Recognition Market in Automotive ... The analysts forecast the Global Gesture Recognition market in ... over the period 2013-2018. Gesture recognition is ... to different gestures of an individual. Gesture recognition technology ...
(Date:3/24/2015)... , Mar. 24, 2015 Research and Markets ... and Voice Biometrics - Global Strategic Business Report" report to ... Face and Voice Biometrics in US$ Thousands by the following Segments: ... for the US, Canada , Japan ... , Middle East & Africa ...
Breaking Biology News(10 mins):Medisafe Announces Launch of Biometric Integration, Enabling Patients to Stay Adherent to Their Meds and See Tangible Health Results 2Global Gesture Recognition Market in Automotive Sector Report 2015 - Growing Number of Partnerships 2Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 2Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 3Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 4Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 5Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 6
(Date:4/16/2015)... (PRWEB) April 16, 2015 Capillus, ... distribution and physician network in Europe and Asia. ... has appointed Fernando Bermúdez, former Business Development Director ... An industry veteran, Mr. Bermúdez’s professional achievements include ... in Spain, while also penetrating the Portuguese marketplace ...
(Date:4/16/2015)... OncoTAb, Inc., a ... spin-out company, announced today the appointment of physician ... Chief Operating Officer (COO). Cooper brings to OncoTAb ... clinical diagnostic and biotechnology platforms in the fields ... extensive career transcends the field of medical and ...
(Date:4/16/2015)... 2015 /CNW/ - Bioenterprise Corporation is pleased to announce that ... Charlottetown , PEI.  Bioenterprise has established a ... Council for the commercialization of agricultural technologies and innovations. ... PEI ADAPT.  They have been at the heart of ... explains Dave Smardon , President & CEO of ...
(Date:4/16/2015)... -- Avelas Biosciences, an in vivo cancer ... that it has initiated a Phase 1b study of ... primary, non-recurrent breast cancer undergoing surgery. In commencing the ... Steven Chen , M.D., as vice president of ... study will enroll up to 39 women with stage ...
Breaking Biology Technology:Capillus, LLC Extends Laser Hair Therapy Products to Europe and Asia 2OncoTAb Names Dr. David L. Cooper as COO 2Bioenterprise Corporation Expands into the Maritimes 2Avelas Biosciences Initiates Phase 1b Trial of AVB-620 in Breast Cancer Patients 2Avelas Biosciences Initiates Phase 1b Trial of AVB-620 in Breast Cancer Patients 3
Cached News: